Cargando…

FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells

Although tissue-resident memory T (T(RM)) cells specific for previously encountered pathogens have been characterized, the induction and recruitment of brain T(RM) cells following immune therapy has not been observed in the context of glioblastoma. Here, we show that T cells expressing fibrinogen-li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Qingnan, Hu, Jiemiao, Kong, Lingyuan, Jiang, Shan, Tian, Xiangjun, Wang, Jing, Hashizume, Rintaro, Jia, Zhiliang, Fowlkes, Natalie Wall, Yan, Jun, Xia, Xueqing, Yi, Sofia F., Dao, Long Hoang, Masopust, David, Heimberger, Amy B., Li, Shulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911733/ https://www.ncbi.nlm.nih.gov/pubmed/36759517 http://dx.doi.org/10.1038/s41467-023-36430-2

Ejemplares similares

FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation
por: Yan, Jun, et al.
Publicado: (2019)

Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme
por: Hu, Jiemiao, et al.
Publicado: (2021)

Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation
por: Yan, Jun, et al.
Publicado: (2019)

A microfluidics-based method for isolation and visualization of cells based on receptor-ligand interactions
por: Dao, Long, et al.
Publicado: (2022)

WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression
por: Wu, Man, et al.
Publicado: (2021)

Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors
por: Hu, Jiemiao, et al.
Publicado: (2022)

FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma
por: Yuan, Kai, et al.
Publicado: (2020)

Induction of NKG2D ligand expression on tumor cells by CD8(+) T cell engagement-mediated activation of nuclear factor-kappa B and p300/CBP-associated factor
por: Hu, Jiemiao, et al.
Publicado: (2019)

Potential Function of Exogenous Vimentin on the Activation of Wnt Signaling Pathway in Cancer Cells
por: Satelli, Arun, et al.
Publicado: (2016)

Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells
por: Hu, Jiemiao, et al.
Publicado: (2014)

Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells
por: Noh, Hyangsoon, et al.
Publicado: (2015)

CD8(+)T cell–specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8(+)T cell accumulation in tumors
por: Hu, Jiemiao, et al.
Publicado: (2014)

Fgl2: link between hepatitis B and SARS?
por: Robertson, Morag
Publicado: (2003)

Targeting FGL2 in glioma immunosuppression and malignant progression
por: Ma, Xiaoyu, et al.
Publicado: (2022)

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis
por: Tang, Xi-Yang, et al.
Publicado: (2022)

Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity
por: Chai, Dafei, et al.
Publicado: (2021)

FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma
por: Lv, Zheng, et al.
Publicado: (2021)

The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection
por: Shalev, Itay, et al.
Publicado: (2010)

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
por: Shi, An-Ping, et al.
Publicado: (2022)

Dynamics of Functionally Graded Laminated (FGL) Media—Theoretical Tolerance Modelling
por: Jędrysiak, Jarosław
Publicado: (2023)

Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile
por: Zhao, Qingnan, et al.
Publicado: (2019)

FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer
por: Sun, Cuilan, et al.
Publicado: (2020)

Regulatory T cells induce polarization of pro-repair macrophages by secreting sFGL2 into the endometriotic milieu
por: Hou, Xin-Xin, et al.
Publicado: (2021)

Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target
por: Qian, Wenjing, et al.
Publicado: (2021)

sFgl2-Treg Positive Feedback Pathway Protects against Atherosclerosis
por: An, Tianhui, et al.
Publicado: (2023)

Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells
por: Noh, Hyangsoon, et al.
Publicado: (2016)

The Fgl2 interaction with Tyrobp promotes the proliferation of cutaneous squamous cell carcinoma by regulating ERK-dependent autophagy
por: Zeng, Mei, et al.
Publicado: (2022)

sFgl2 gene-modified MSCs regulate the differentiation of CD4(+) T cells in the treatment of autoimmune hepatitis
por: Ji, Wenbin, et al.
Publicado: (2023)

FGL-GAN: Global-Local Mask Generative Adversarial Network for Flame Image Composition
por: Qin, Kui, et al.
Publicado: (2022)

Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma
por: Yan, Qing, et al.
Publicado: (2022)

Inhibition of rhotekin exhibits antitumor effects in lung cancer cells
por: ZHANG, WEIZHEN, et al.
Publicado: (2016)

Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation
por: Liu, Xin-guang, et al.
Publicado: (2016)

Abnormal Expression of the LAG-3/FGL-1 Signaling Pathway in Patients with Early-Onset Preeclampsia
por: Liang, Yue, et al.
Publicado: (2022)

The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer
por: Li, Jia-Jun, et al.
Publicado: (2023)

Mesenchymal stem cells transfected with sFgl2 inhibit the acute rejection of heart transplantation in mice by regulating macrophage activation
por: Gao, Chao, et al.
Publicado: (2020)

Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
por: Lutz, Martina Svenja, et al.
Publicado: (2022)

Soluble FGL2, a novel effector molecule of activated hepatic stellate cells, regulates T-cell function in cirrhotic patients with hepatocellular carcinoma
por: Sun, Ying, et al.
Publicado: (2014)

Scorpion Peptide Smp24 Exhibits a Potent Antitumor Effect on Human Lung Cancer Cells by Damaging the Membrane and Cytoskeleton In Vivo and In Vitro
por: Guo, Ruiyin, et al.
Publicado: (2022)

Herceptin Conjugates Linked by EDC Boost Direct Tumor Cell Death via Programmed Tumor Cell Necrosis
por: Hu, Jiemiao, et al.
Publicado: (2011)

Immunosuppressive role of fibrinogen-like protein 2 (FGL2) in CD8(+)regulatory T cells-mediated long-term graft survival
por: Bézie, Séverine, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_034lfof9ermksgfhsg1k731ci0